FirstICE / Gel-Pack Manufacturing Insourcing & Cost-Reduction Program
A make-versus-buy manufacturing program that brought cryotherapy gel-pack capability in-house and materially changed the economics of a core product platform.
Results and contributions.
Historical cost-model calculation.
Operating context
PPI was purchasing cryotherapy gel-pack capability externally and had an opportunity to bring formulation and pack production in-house to improve control and support the broader FirstICE product platform.
What made the work difficult
The decision required separating raw-material cost from complete manufactured cost, transferring a process into internal operations, acquiring equipment and materials, and scaling production without exposing proprietary formulation details.
Responsibility and authority
Dean led the operating side of the make-versus-buy decision and the insourcing program, including internalization priorities, cost analysis, manufacturing integration, and implementation governance.
How the work moved forward
- Led the make-versus-buy decision to internalize cryotherapy gel-pack manufacturing.
- Coordinated formulation, raw-material, equipment, personnel, and process requirements for the transfer.
- Integrated the new capability into regulated medical-device manufacturing operations.
- Established cost tracking that distinguished purchased cost from internally manufactured economics.
- Connected the insourced capability to the broader FirstICE product platform.